发明名称 Proliposomal testosterone formulations
摘要 Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder dispersions of the invention may be formulated with phamarceutically acceptable excipients to form pharmaceutical compositions. Enterically coated oral dosage forms are disclosed as are methods of treatment for testosterone replacement therapy.
申请公布号 US9445995(B2) 申请公布日期 2016.09.20
申请号 US201514604985 申请日期 2015.01.26
申请人 WESTERN UNIVERSITY OF HEALTH SCIENCES;TESORX PHARMA, LLC 发明人 Betageri Guru V.;Thirucote Ramachandran;Kadajji Veeran Gowda
分类号 A61K9/12;A61K9/10;A61K9/127;A61K31/568;A61K31/575;A61K9/14;A61K9/19;A61K9/20;A61K9/48;A61K9/28 主分类号 A61K9/12
代理机构 J.A. Lindeman & Co., PLLC 代理人 J.A. Lindeman & Co., PLLC
主权项 1. A method of preparing a proliposomal powder dispersion, wherein the powder dispersion consists essentially of native testosterone, cholesterol, and at least one phospholipid, the method comprising: (a) dissolving native testosterone in a water miscible solvent until the solution is clear; (b) obtaining a dispersion of native testosterone, phospholipid and cholesterol by adding a phospholipid to the clear solution of native testosterone and water miscible solvent, and subsequently adding cholesterol to the mixture of the solution of native testosterone and water miscible solvent and phospholipid to obtain a dispersion of testosterone, phospholipid and cholesterol, wherein the native testosterone and cholesterol are added in a weight ratio (native testosterone):(cholesterol) ranging from 1.0:0.05 to 1.0:0.30, and the phospholipid is added such native testosterone, cholesterol and phospholipid are present in a weight ratio of (native testosterone): ((cholesterol)+(phospholipid)) ranging from 1:0:1.0 and 1.0:2.5; and (c) removing the water miscible solvent by evaporation until a dry powder is obtained.
地址 Pomona CA US